A venture investment and development firm based in the Southern United Sates provides investment and incubation services to start-up and early-stage medical device companies. The firm provides seed capital (equity) ranging from $500K to $2M with follow-on capital of up to $5M. The firm also considers investment opportunities with smaller than typically accepted venture capital market size thresholds. The firm is geographically agnostic and is actively seeking new opportunities.
The firm is currently looking for medical device companies/start-ups developing products with a 510(k) regulatory pathway. The firm primarily focuses on Class II medical devices but will also consider Class III. Preferably, the product should have a prototype and animal data. The firm is open to all target markets, but is more interested in cardiovascular, interventional cardiology, interventional radiology, cardiac surgery, vascular surgery, critical care, consumable product, patient care, and orthopedic markets.
The firm takes an active role in the management of portfolio companies. The firm seeks Board representation and participation as Executive Management.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment